DETERMINANTS OF ATHEROSCLEROSIS IN CAPD PATIENTS - ROLE OF APOPROTEIN (A) ISOFORM, LIPOPROTEIN(A) AND FIBRINOGEN SERUM LEVELS

被引:0
|
作者
BARTENS, W [1 ]
NAUCK, M [1 ]
SCHOLLMEYER, P [1 ]
WANNER, C [1 ]
机构
[1] UNIV CLIN FREIBURG,DEPT MED,FREIBURG,GERMANY
来源
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:487 / 487
页数:1
相关论文
共 50 条
  • [41] The relationship between circulating fibrinogen and lipoprotein (a) levels in patients with primary dyslipidemia
    Ganotakis, Emmanuel S.
    Gazi, Irene F.
    Papadakis, John A.
    Jagroop, I. Anita
    Nair, Devaki R.
    Mikhailidis, Dimitri P.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2007, 13 (01) : 35 - 42
  • [42] Atherosclerosis in SLE: a potential role for serum parathormone levels
    Giannelou, Mayra
    Skarlis, Charalampos
    Stamouli, Aikaterini
    Antypa, Eleni
    Moutsopoulos, Haralampos M.
    Mavragani, Clio P.
    LUPUS SCIENCE & MEDICINE, 2020, 7 (01):
  • [43] Type of diabetes and waist-hip ratio are important determinants of serum lipoprotein (a) levels in diabetic patients
    Nawawi, HM
    Muhajir, M
    Kian, YC
    Mohamud, WNW
    Yusoff, K
    Khalid, BAK
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 56 (03) : 221 - 227
  • [44] Study on the levels of glycosylated lipoprotein in patients with coronary artery atherosclerosis
    Luo, Wei
    He, Yong
    Ding, Fei
    Nie, Xin
    Li, Xiao-Ling
    Song, Hao-Lan
    Li, Gui-Xing
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2019, 33 (01)
  • [45] Role of Lipoprotein Levels and Function in Atherosclerosis Associated with Autoimmune Rheumatic Diseases
    Ronda, Nicoletta
    Zimetti, Francesca
    Adorni, Maria Pia
    Palumbo, Marcella
    Karpouzas, George A.
    Bernini, Franco
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2023, 49 (01) : 151 - 163
  • [46] PROTEIN LOSS AND GENETIC-POLYMORPHISM OF APOLIPOPROTEIN(A) MODULATE SERUM LIPOPROTEIN(A) IN CAPD PATIENTS
    WANNER, C
    BARTENS, W
    WALZ, G
    NAUCK, M
    SCHOLLMEYER, P
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (01) : 75 - 81
  • [47] Serum levels of oxidized low density lipoprotein relate to the extent and severity of coronary atherosclerosis in patients with coronary syndromes
    Koulouris, S.
    Triantafyllou, K. A.
    Dasopoulou, C.
    Symeonides, R.
    Michaelides, I.
    Karabinos, I.
    Papapanagiotou, A.
    Nounopoulos, C.
    Kalofoutis, A.
    Manolis, A. S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 67 - 67
  • [48] AGE-RELATED-CHANGES OF SERUM APOPROTEIN SASSAM, APOPROTEIN A-I AND LOW-DENSITY LIPOPROTEIN LEVELS IN SENESCENCE ACCELERATED MOUSE (SAM)
    HIGUCHI, K
    MATSUMURA, A
    HONMA, A
    TODA, K
    TAKESHITA, S
    MATSUSHITA, M
    YONEZU, T
    HOSOKAWA, M
    TAKEDA, T
    MECHANISMS OF AGEING AND DEVELOPMENT, 1984, 26 (2-3) : 311 - 326
  • [49] SERUM-LIPOPROTEIN LIPID AND APOPROTEIN LEVELS AS INDICATORS OF THE SEVERITY OF ANGIOGRAPHICALLY ASSESSED CORONARY-ARTERY DISEASE
    ARO, A
    SOIMAKALLIO, S
    VOUTILAINEN, E
    EHNHOLM, C
    WILJASALO, M
    ATHEROSCLEROSIS, 1986, 62 (03) : 219 - 225
  • [50] LIPOPROTEIN AND APOPROTEIN A1 LEVELS IN DIABETICS AND CORONARY HEART-DISEASE PATIENTS AND CONTROLS
    PAN, XR
    HU, SX
    GANG, Y
    JIN, L
    LI, XG
    LI, J
    YAN, Q
    CHEN, TS
    CHINESE MEDICAL JOURNAL, 1987, 100 (03) : 204 - 207